Prometheus

Supreme Court orders reconsideration of breast cancer gene patent decision

Yesterday, the Supreme Court vacated Association for Molecular Pathology v. Myriad Genetics and remanded the case for further consideration in light of last week's Prometheus decision, which stated that the laws of nature are unpatentable. The Myriad case concerns the patentability of the BRCA1 and BRCA2 breast cancer genes. » Read more

3 Comments

Prometheus bound: An important precedent for the next software patent case

Supreme Court

The Supreme Court’s new opinion on patent eligibility is an important step in the right direction in addressing the problem of software patents. It shows that the Court is mindful of the risks that patents can hold for innovation, and will provide a useful precedent for the next big software patents case.  » Read more

37 Comments